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Summary.-Fifty-nine children with Hodgkin's disease were seen over a 34-year
period. Compared with Hodgkin's disease in adults, there was an increased male
incidence, especially in the younger children. This was associated with an increased
male incidence of lymphocyte-predominant histology. Forty-six patients underwent
lymphography as part of their staging, and 13 had staging laparotomies. The 5-year
survival for the entire group was85%, with a median survival of 10 years. Response to
radiotherapy in children with Stages I-IIIA disease was: 12 children treated with
involved-field radiotherapy after inadequate clinical staging had a 3-year remission
rate of 13%, and a median length of remission of 18 months; 24 children treated with
extended-field radiotherapy after adequate clinical staging, including lympho-
graphy, had a 3-year remission rate of72%, and a median duration of remission not
yet reached; 3 children treated with elective local radiotherapy for Stage IA disease
after intensive clinical staging remain in complete remission for periods of up to
34 months. Eight out of 10 children with Stages IIIB-IV disease, treated with com-
bination chemotherapy, achieved complete remission with a 3-year remission rate
of 70%; 7 children treated with combination chemotherapy following relapse after
radiotherapy all achieved complete remission with a 3-year complete remission rate
of 66%. Thirteen children underwent laparotomy and splenectomy as a staging
procedure. Five were found to have intra-abdominal disease, including 4 with splenic
involvement. These results show that there is no place for involved-field radio-
therapy after inadequate clinical staging, in the management of childhood Hodgkin's
disease. Extended-field radiotherapy after adequate staging, and combination
chemotherapy, produce results which are as good as those for adults, but the benefits
of these treatments and of staging laparotomy must be balanced against the possible
complications when they are used in children. These problems are discussed and a
scheme of management is proposed.
NEW methods of investigating and
treating Hodgkin's disease have greatly
improved prognosis. Many patients can
now look forward to long survival and
probable cure. As survival increases, we
must assess the immediate risks and pos-
sible long-term effects of treatment, in
planning the best treatment for each
patient. In children with Hodgkin's dis-
ease, these factors are particularly im-
portant, and treatment must be designed
to minimize possible hazards without
reducing the chance of cure.
The clinical presentation and natural
history of Hodgkin's disease in European
and North American children are broadly
similar to that in adults, although the
overall incidence is lower and the male
incidence higher (Fraumeni and Li, 1969;
Jenkin, Peters and Darte, 1967; Schnitzer
et al., 1973; Strum and Rappaport, 1970;
Young, De Vita and Johnson, 1973). But
it is by no means clear that treatment
should be the same as for adults in every
case. Extended-field radiotherapy employ-
ing "Mantle", "inverted Y", or "total
nodal" techniques (for definition see
Table I) for local disease is at present
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TABLE I. Radiotherapy Techniques
1. Involved-field radiotherapy: radiotherapy to sites
of involvement only.
2. Local radiotherapy: radiotherapy to sites of
involvement and to adjacent nodal sites, but
notextended to include the full mantle, inverted
Y or total nodal fields.
3. Extended-field radiotherapy:
(i) Mantle: en-bloc irradiation of the media-
stinal, axillary and cervical nodal areas
using large anterior and posterior fields,
the majority ofpatients being treated with
a linear accelerator.
(ii) Inverted Y: en-bloc irradiation of para-
aortic, iliac and inguinal nodes, usually
with a linear accelerator.
(iii) Total-nodal radiotherapy: mantle treat-
ment followed after an interval of one
month by inverted Y treatment.
considered by many to be the treatment of
choice in children as well as adults (Jenkin
et al., 1975; Young et al., 1973). On the
other hand Fuller, Sullivan and Butler
(1973) have shown that local radio-
therapy (see Table I) in children who have
been accurately staged by lymphography
and laparotomy is as effective as extended-
field treatment, with less risk of growth
complications. Furthermore, limited ex-
perience with combination chemotherapy
in the treatment of early-stage Hodgkin's
disease in Ugandan children has produced
results comparable with radiotherapy in
other centres (Ziegler et al., 1972; Olweny
et al., 1974).
We describe 59 children with Hodgkin's
disease treated at The Royal Marsden
Hospital by various techniques over a 34-
year period. Many of these children were
seen recently, when techniques oflympho-
graphy, laparotomy, extended-field radio-
therapy and combination chemotherapy
were available. This has allowed a pre-
liminary assessment of the value of such
methods in the overall management of
childhood Hodgkin's disease and its com-
parison with earlier approaches to treat-
ment.
PATIENTS AND METHODS
Patients.-Fifty-nine children with Hodg-
kin's disease were treated at The Royal
Marsden Hospital between 1941 and Septem-
ber 1975. Their ages ranged from 3 to 15
years at the time ofdiagnosis with 21 children
in the 3-10 age-group and 38 between 11 and
15 years. Most presented in recent years:
only one child was seen between 1941 and
1947, 7 from 1950 to 1959, 12 from 1960 to
1969 and 39 from 1970 to 1975. Thirty-seven
children were boys and 22 girls. This increased
male incidence was most marked in the
youngest age group (3-6 years) with 9 boys
and one girl, and fell as age increased: there
were 6 boys and 2 girls of 7-9 years, 12 boys
and 6 girls of 10-12 years, and 10 boys and
13 girls of 13-15 years (Fig. 1).
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FIG. 1. Male: female ratio of childhood
Hodgkin's disease with age. Royal Mars-
den Hospital data and other studies.
Histology.-The histology of all but 3
biopsy specimens was reviewed at this hospi-
tal, and classified according to the criteria of
Lukes and Butler (1966) as "lymphocyte
predominant" (LP), "nodular sclerosing"
(NS), "mixed cellularity" (MC) or "lympho-
cyte depletion" (LD).
Staging.-Each child was clinically staged
using the Ann Arbor classification (Carbone
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et al., 1971), and patients presenting before
1972 were retrospectively restaged as far as
possible according to the same classification.
Bilateral lower-limb lymphangiography was
carried out in 46 children.
More recently, 13 children underwent
laparotomy with splenectomy, multiple
lymph-node, liver and iliac-crest biopsy
specimens as an initial staging procedure
(Gazet, 1973). With one exception, a child of
8 years with clinical Stage IIIA disease, all
these children were 10 years old or more (age
range 8-15) and laparotomy was considered
justified at the time, in view of its proven
value in the management of adults (Peckham
et al., 1975) and the potential radiocurability
of all of them. Six others also had lapar-
otomies with splenectomylaterinthecourseof
their disease, to confirm suspected intra-
abdominal relapse.
Thus, staging for the whole group was as
follows: "inadequate" clinical staging without
lymphography, 13; "adequate" clinical stag-
ing including lymphography, 33; and patho-
logical staging with laparotomy as well as
lymphography, 13.
Radiotherapy.-Thirty-nine children were
first treated byradiotherapy alone. They have
been subdivided into 3 groups:
(1) 12 children had limited and inadequate
radiotherapy in which involved fields
were irradiated, using low doses in
inadequately staged patients.
(2) 24 children had extended-field radio-
therapy, using the "mantle" or "in-
verted Y" techniques for Stages I and
II, and "total nodal" irradiation for
Stage IIIA (see Table I and also
Peckham, 1973). Patients in this group
all had lymphograms, but only 11 had a
staging laparotomy.
(3) 3 children had "elective" local radio-
therapy: these were found, after full
clinical staging with lymphography, to
have disease localized to high left-sided
cervical nodes, and were treated with
irradiation to both sides of the neck,
but not to the mediastinum or axillae.
Considerable care was taken to ensure
accuracy and symmetry of the irradia-
tion field, patients being irradiated in
perspex casts.
Except in a few early cases, most children
in this series received a total tumour dose of
3000-3500 rad, with 5 fractions per week over
a4-week period, or, where total nodal irradia-
tion was employed, over two 4-week periods
separated by a month.
Chenmotherapy.-Elevenchildren weretreat-
ed initially with chemotherapy. Ten had
quadruple combination chemotherapy (Table
II). Seven were given standard MOPP
(mustine, vincristine, procarbazine and pred-
nisone) (De Vita, Serpick and Carbone, 1970),
TABLE II.-Responses of Children with
Hodgkin's DiseasetoCombinationChemo-
therapy (MOPP, MVPP or ChlVPP)
Complete
remission
3-year
remission
No
previous
treatment
80%
(8/10)
70%
Relapse
after
RT
100%
(7/7)
66%
Total
88%
(15/17)
67%
or MVPP (mustine, vinblastine procarbazine
and prednisone) (McElwain et al., 1973), and
3 received a similar quadruple drug regime,
substituting chlorambucil 6 mg/M2 daily x
14 for mustine (ChlVPP). The eleventh
patient was treated with the single agent
triphenyl-methyl-ethylene in 1941, with no
success.
Seven children received combination
chemotherapy following relapse after radio-
therapy. All achieved complete remission.
Other therapy.-One child was initially
treated by surgical excision alone, in 1952.
Details of initial therapy are unavailable in
3 patients and, in another 5, treatment was
begun too recently to assess response in this
study.
RESULTS
Histology
Histological classification was as fol-
lows: LP, 13 (22%), NS, 32 (54%), MC,
9 (15%) and LD 2 (3%). No histological
review was possible in 3 patients.
The relationship ofhistology to age and
sex is shown in Fig. 2. It is ofinterest that
LP disease was much more common in
males (32%) than females (5%), a finding
which differed from experience with adult
Hodgkin's disease at this hospital, where
the frequency of LP disease was approxi-
mately equal in males and females (Fig. 3).
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FIG. 2. The relatioiiship of histology to age
aIn(l sex in childhood Hodgkin's (lisease.
(M: male; F: female.)
Otherwise, the distribution ofhistology by
sex was similar for children and adults
(Fig. 3).
Staging
The frequency of each stage, and its
relationship to sex and histology, is shown
in Fig. 4. Most patients presented with
Stages I or II: 12 (20%) Stage I and 30
(5o1) Stage II. Ten children (l7%o) were
staged IIA and only 7 (12%) presented
with advanced disease (Stages IIIB or IV).
The stage distribution might, of course,
have been modified by lymphography in
the early years and by routine staging
laparotomv.
It is of interest that all but one of the
children with LP disease presented as
Stage I or II.
Survival
The 5-year survival (life table analysis)
for the whole group is 85%, and the
median survival is 10 years (Fig. 5).
Females may have a slightlv better
survival than males up to 10 vears from
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diagnosis, by which time numbers become
very small.
There was no correlatioii between histo-
logical type and survival in this series,
except for lymphocyte depletion (LD).
One ofthe two children with this histology
died within 4 months of diagnosis, and the
other was in relapse 3 months after starting
chemotherapy, suggesting that LD Hodg-
kin's disease has as bad a prognosis in
children as in adults.
Response to radiotherapy
Those treated primarily by irradiation
were subdivided into 3 groups, as defined
above. Details of remission duration for
each group are shown in Fig. 6.
Of the 12 children in the first group
(limited radiotherapy in inadequately
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FIG. 4.-The relationship of staging to histology
in childhood Hodgkin's disease.
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FIG. 5. Survival in childhood Hodgkin's disease.
(Life table analysis.)
staged patients) one failed to achieve
remission and 9 relapsed; the complete
remission rate was 13% at 3 years, and the
median duration of remission was 18
months (Fig. 6). Six of the 12 children in
this group subsequently died.
Of 24 children receiving extended-field
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FIG. 6.-Duration of first remission after:
limited radiotherapy, extended-field radio-
therapy, elective local radiotherapy
and combination chemotherapy. (Life
table analysis.)
radiotherapy, 7 relapsed and one subse-
quently died. The 3-year complete remis-
sion rate was 72%, and the median dura-
tion of remission has not yet been reached
(Fig. 6).
All 3 children receiving elective local
radiotherapy after full clinical staging
were in complete remission, at 15, 20 and
34 months respectively.
Response to chemotherapy
Ten childrenreceived combination quad-
ruple chemotherapy as primary treatment.
Eight achieved complete remission. The
3-yearcompleteremissionrateofthisgroup
was 70%, and the median duration of
remission has not yet been reached. None
of the group has died.
Seven other children who had relapsed
after radiotherapy were also treated with
combination chemotherapy (MOPP or
MVPP). All achieved complete remission,
and 2 have subsequently relapsed. The
3-year complete remission rate for this
group is 66%.
Thus a total of 17 children were treated
with combination chemotherapy, either at
presentation or at relapse after radio-
therapy. Fifteen of the 17 achieved com-
plete remission (88%) with an overall
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3-year remission rate of 67%, and a
median duration of complete remission
not yet reached (Table II).
The most frequent side-effect from
chemotherapy was nausea and vomiting
shortly after each course of mustine, but
the severity of this was very variable.
Severe bone-marrow depression with life-
threatening infection was seen in only one
patient, after 10 courses of MVPP pre-
ceded by mantle radiotherapy, and this
should not normally be a serious problem,
provided the peripheral blood count is
checked before each course.
Sites of relapse after extended-field radio-
therapy and laparotomyfindings
The sites of relapse in the 7 children
relapsing after extended-field radiotherapy
are shown in Table III. Two of these had
laparotomies at the time of diagnosis, and
both relapsed in previously treated areas
above the diaphragm. In one child present-
ing with a chylous effusion, there was
clearly lung infiltration (in retrospect), and
this patient would to-day have been treat-
ed with chemotherapy. The other 5 were
clinically staged without laparotomy of
which 4 had intra-abdominal relapses
involving the spleen. The fifth had a
marginal recurrence in a right submandi-
bular node outside the original mantle
field, and after further radiotherapy
remains in complete remission.
Clinical details and findings at lapar-
otomy in the 13 children who had this
procedure during initial staging are shown
in Table IV. Five of the 13 had positive
findings: 4 of these had splenic involve-
ment, 4, involvement ofthe para-aortic or
pelvic nodes, and 3, involvement of the
porta hepatis nodes. It was ofinterest that
one patient with involvement of a porta
hepatis node (Table IV, C.W.) had no
histological evidence of splenic involve-
ment. None ofthe 5 with positive findings
at laparotomy were down-staged by this
procedure. One child was up-staged by a
negative laparotomy after a positive
lymphogram (Table IV, G.K.) but an
intervening single course of quadruple
chemotherapy may well have produced a
spurious result here. None of the 3 clini-
cally-staged IA children had a positive
laparotomy.
Five of the 6 children who had laparo-
tomy after primary therapy because of
suspected intra-abdominal relapse hadthis
diagnosis confirmed by the procedure: all
had splenic involvement.
None of the 19 liver and iliac-crest
biopsy specimens in the two groups were
positive. There were no serious complica-
tions after any ofthe 19 laparotomies, and
in particular no patient has developed
pneumococcal septicaemia, a recognized
complication of splenectomy in childhood
(Chilcoate et al., 1975).
Since the beginning of 1976, it has been
our practice to give prophylactic oral
penicillin to all our splenectomized
patients under the age of 15, and this
may account for their freedom from late
infective complications.
TABLE III.-Sites ofRelapse in Patients Treated with Extended-field (Mantle)
Radiotherapy after Adequate Staging
Staging
laparotomy
Patient Age Sex Histology Clinical stage (findings)
T.Ha. 15 F NS IIB (ad)* Yes (-ve)
G.K. 15
T.H. 15
A.S. 9
C.Y. 15
E.F.
C.L.
M
F
M
M
NS
NS
NS
LP
IIIB
IIA (ad)
IIA (ad)
IIA (ad)
11 M LP IIB (ad)
14 F NS IIA (ad)
Yes (-ve)
No
No
No
No
No
Site ofrelapse
Local recurrence (hilum and
lung)
Local recurrence
Spleen
Spleen
Marginal recurrence (right
submandibular node)
Spleen and para-aortic nodes
Spleen and lung
* ad = above diaphragm.
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TABLE IV.-Findings at Staging Laparotomy in Children with Hodgkin's Disease
Clinical sites
Hist- of involvement
Patient Age Sex ology (clinical stage)
M.J. 8 M MC L. neck, spleen (IIIA)
P.K. 13 M MC R. neck, para-aortic
nodes (IIIA)
T.W. 15 M NS L. neck, R. groin (IIIB)
C.W. 12 F NS R.neck,R.andL.
axillae, spleen (IIIA)
A.A. 10 M NS R. neck and
mediastinum, spleen
(IIIA)
W.B. 13 F NS R. and L. neck,
nasopharynx (IIA)
T.H. 15 F NS L. neck, mediastinum,
pleural effusion
(IIE B)
G.K. 15 M NS R. and L. neck,
mediastinum, para-
aortic nodes (IIIB)
T.W. 15 M LP Left neck (IA)
I.B. 12 F MC L3ft neck, mediastinum
(IIA)
R.G. 12 M NS R. neck (IA)
C.C. 11 M NS L. neck (IA)
C.S. 13 F NS L. neck, mediastinum
(IA)
Total 13
Lapar-
otomy
finding
Porta
hepatis
Spleen Nodes node
+ +
+ + +
+ +
+
5 4 4 3 0 0
Late complications after primary therapy
Two children developed hypothyroidism
one and 3 years after mantle irradiation.
There were no serious growth disturbances
in the group, except that one boy showed
slight maldevelopment ofthe thoracic cage
with depressed respiratory function tests,
7 years after mantle irradiation.
Two second malignancies occurred: at
the age of 19, one girl developed the bone-
marrow and peripheral-blood appearances
of chronic lymphocytic leukaemia, 3 years
after therapy which included both mantle
irradiation and 10 courses of MVPP; a
second girl, aged 20 developed carcinoma
ofthe uterine cervix 8 years after inverted
"Y" radiotherapy and 4 years after
MVPP chemotherapy. It is ofinterest that
the cervical cancer was preceded by
multiple vulval and vaginal condylomas.
DISCUSSION
Hodgkin's disease in children behaves in
a similar way to the disease in adults.
These are geographical differences in the
incidence of childhood Hodgkin's disease
(McMahon, 1966) but in western countries
the disease is uncommon in children,
particularly in the very young, and
increases with age (Fraumeni and Li,
1969; Jenkin et al., 1967; Young et al.,
1973). The higher incidence in males than
in females in our study confirms the ex-
perience ofothers (Fraumeni and Li, 1969;
Schnitzer et at., 1973; Strum and Rappa-
port, 1970; Tan et al., 1975; Young et at.,
1973) and, at least in the very youngest
age groups, is much more marked than the
slightly increased male incidence reported
for adults (McMahon, 1966).
In this study, more than 70% of chil-
dren treated with chemotherapy or radio-
therapy, based in most instances on
clinical staging, are disease free and this,
together with the predicted overall median
survival of 10 years, reflects the benefits of
modern therapy, as others have also
demonstrated (Jenkin et al., 1975; Tan
et al., 1975). It is clear that therapy should
be designed to minimize complications and
long-term sequelae, as much as to improve
techniques for disease eradication. How-
ever, low-dose involved-field radiotherapy
Liver Marrow
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in patients who have been inadequately
staged results in a 3-year complete remis-
sion rate of only 13%, and is inadequate
for controlling disease. Extended-field
radiotherapy, including adjacent lymph-
node groups, after adequate staging with
lymphography, gaveamuchbetterdisease-
free survival with a 3-year rate of 72%.
Others have reported similar results
(Jenkin et al., 1975; Young et al., 1973),
and it is important to consider, with these
results in mind, whether extended-field
radiotherapy should be the treatment of
choice for localized disease in children, as
it is now for adults. In this context the
potential hazards of bone-growth impair-
ment and organ maldevelopment need to
be considered. Probert, Parker and Kap-
lan (1974) reported a retardation of spinal
growth in 16/22 children receiving com-
plete spinal irradiation, but it is important
to point out that the doses employed were
considerably higher than those habitually
used at this centre. Young et al. (1973)
noted retardation in vertebral body
growth after extended-field radiotherapy,
particularly in younger children; and one
child in our series has developed thoracic
deformity and impaired lung function
after mantle irradiation, but again, after
receiving a dose ofmore than 4000 rad to a
generous field. In children as in adults,
hypothyroidism may result from irradia-
tion of the thyroid. Gonadal irradiation
may result in infertility, but does not
appear to interfere with the other normal
changes occurring at puberty.
It is important, therefore, to question
the routine use of this extended-field
approach, particularly in early childhood,
and clearly pertinent to this istheperform-
ance of chemotherapy as a method of
primary treatment ofHodgkin's disease in
children. It is also important to identify
children who may respond satisfactorily to
local field irradiation for Stage I disease.
In our study, 3 children with Stage IA
upper-cervical-node involvement had elec-
tive local radiotherapy limited to both
sides of the neck, and remain disease-free.
This experience is obviously too small to
9
allow us to draw conclusions, but Fuller
et at. (1973) previously reported that local
radiotherapy in children adequately staged
by lymphography and laparotomy may be
as effective as extended-field radiotherapy,
with less risk ofgrowth complications. The
importance of adequate staging where
such therapy is to be contemplated cannot
be over-emphasized: lymphography is an
essential staging procedure and there is a
good argument for laparotomy and splen-
ectomy prior to irradiation, at least in
children of 11 years and older, since the
radiotherapy results obtained in adults
staged by laparotomy have shown a con-
siderable improvement over those obtain-
ed in clinically staged patients (Peckham
et al., 1975).
Combination chemotherapy achieved a
remission rate comparable to that in
adults. So far, the results in the chemo-
therapy group are comparable with those
observed in the radiotherapy group (Fig.
6). This finding must be qualified by the
small number of patients in the chemo-
therapy group, and by the fact that 7/10
children treated primarily by chemo-
therapy are still less than 2 years from the
start of treatment. Nevertheless, our data
so far support those of Ziegler et al. (1972)
and Olweny et al. (1974) who gave com-
bination chemotherapy to Ugandan chil-
dren with early-stage disease, albeit of
different histological distribution to our
series, and achieved results comparable
with other series where treatment was by
conventional extended-field radiotherapy.
Combination chemotherapy has its own
disadvantages: sterility in males, at least
for a time after treatment, is almost
inevitable (De Vita et al., 1973) although
the extent to which this will remain along-
term problem in male children is so far
unknown. The inductionofsecondtumours
is a risk which remains to be assessed. The
major attraction of chemotherapy, parti-
cularly in young children, is the avoidance
of the sequelae of irradiation in grcwing
bone, since serious problems of growth
disturbance do not appear to occur with
chemotherapy (Young et al., 1973) and
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certainly local malformations aftertherapy
are not a problem. Chemotherapy, if
employed alone, further obviates the need
for a staging laparotomy with splen-
ectomy. Finally, even ifrelapse does occur
after chemotherapy, radiotherapy may
well remain a curative treatment in many
instances, and perhaps at a later stage in
the child's development, when growth
problems are less likely.
Laparotomy with splenectomy as a
staging procedure in childhood Hodgkin's
disease presents a difficult problem. Its
rationale, as in adults, is to diagnose or
exclude occult intra-abdominal disease,
especially in the spleen, and so to plan
more confidently an irradiation field that
should be effective without including more
uninvolved normal tissuethanisnecessary.
On this basis, the procedure has a particu-
lar attraction in children, in whom the
importance oflimiting the irradiation field
and hence the risk of long-term sequelae
has been emphasized. However, the opera-
tion is not a minor one, and while our
group of children has escaped serious post-
operative complications, severe infections
and deaths have been recorded in children
after the procedure (Jenkin et al., 1975;
Hays et al., 1972; Rosenberg, 1971).
More recently Chilcoate et al (1975) have
documented 20 episodes of septicaemia
and/or meningitis in 200 children, follow-
ing diagnostic laparotomy and splen-
ectomy. Eleven of these children died.
They emphasize the frequency of peni-
cillin-sensitive organisms, the most fre-
quent being D. pneumoniae, and we would
strongly support their recommendation
that splenectomized children should re-
ceive prophylactic penicillin.
Five of the 13 children undergoing
laparotomy in our group had positive
findings and, although in none of these
was staging or treatment changed, no
child in the group had an intra-abdominal
relapse after laparotomy, whereas 4 chil-
dren relapsed in spleen or abdominal
nodes after complete clinical staging but
without laparotomy; conceivably, occult
disease might have been diagnosed and
eradicated in some of these at diagnosis,
had they undergone the procedure. A more
clearly established role for chemotherapy
in early stage disease would, of course,
bring with it the benefit of avoiding the
need for the operation; but at present we
feel that in children of 11 years and older,
the advantages of laparotomy and splen-
ectomy outweigh the possible risks, and
that the procedure should be carried out
where radiotherapy which includes pos-
sible intra-abdominal sites of disease is
contemplated. This policy may need to be
modified in the light of future experience
with chemotherapy.
It is clear that the management of
children's Hodgkin's disease needs very
considerable individualization, with dis-
ease site, histology and particularly age
of the patient being taken into account.
Patients in later childhood, for example,
can be managed essentially as adults,
whilst in the younger child, avoidance of
surgical staging procedure and extended-
field radiotherapy may be of paramount
importance.
We can, therefore, summarize our
present philosophy of treatment as
follows:
In children of 10 years or less, where
laparotomy would be a hazard, lympho-
graphy is performed, and they are then
treated with chemotherapy when there is a
positive lymphograph or where histology
(MC or LD) indicates that there is a very
substantial risk ofabdominal involvement.
In children with localized disease and
prognostically favourable histology (LP or
NS) local irradiation to the tumour-bear-
ing lymph node area is given first. Children
with Stage IV disease are treated with
chemotherapy.
In children of 11 years and over the
patients are pathologically staged by
laparotomy and splenectomy (unless there
is obvious Stage IV disease). Children
with pathological Stages I or II disease are
treated with extended-field radiotherapy
unless there are more than 3 nodal areas
involved, particularly when infra-clavicu-
larnode involvement or alarge mediastinal
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mass are present, since these features are
known to be associated with a very low
cure rate for radiotherapy alone (Peckham
et al., 1975). Here chemotherapy is given
first, to achieve good tumour regression
before irradiation. In Stage IIIA (with a
negative spleen) treatment will depend
upon the age ofthe child. It is our policy to
treat children of 13 or over with total
nodal irradiation as in adults. In younger
children we prefer to use chemotherapy, in
an attempt to minimize damage to the
growing spine. When the spleen is involv-
ed, and in Stage IIIB disease, chemo-
therapy, which may be followed by irradi-
ation to sites of bulky disease, is given. In
Stage IV, chemotherapy alone is given, as
it is in adults. All splenectomized children
receive oral prophylactic penicillin until
the age of 15 years.
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